InternationalExplained: Moderna's Cancer And Heart Vaccines Could Be Made By 2030, What's Science Behind Them?BY Madhur Sharma
InternationalUSA: Florida's Top Health Official Advises Against Covid mRNA Vaccines, Cites High Risk Of Heart Side EffectsBY Outlook Web Desk
NationalGennova Biopharmaceuticals Is Ready To Roll Out 70 Lakh Doses Of Its Gemcovac-19 vaccineBY PTI
InternationalFourth Vaccine Dose Protects Elderly From COVID-19 But Protection Wanes Quickly: StudyBY Outlook Web Desk
Making A DifferenceCovid-19 Vaccines: US CDC Panel Recommends Pfizer, Moderna Over J&J ShotBY Outlook Web Desk
Making A DifferenceOmicron Variant: South Africa Develops Indigenous Covid-19 VaccineBY Outlook Web Desk
Making A DifferenceOmicron Covid-19 Variant Expected To Be Dominant By Mid January: EU OfficialBY Outlook Web Desk
Making A DifferenceCovid-19: Pfizer Vaccine Not Effective Against Omicron Like Delta, Finds South Africa AnalysisBY Outlook Web Desk
NationalCovaxin Gets WHO Nod For Emergency Use: What That Means For Indian TravelersBY Outlook Web Desk
Making A DifferenceUS: 5 To 11-Year-Old Kids May Get Covid-19 Vaccine Soon As FDA Panel Endorses Pfizer ShotsBY Associated Press
.png?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
